Clorox Co (CLX) financial statements: income statement, balance sheet and cash flow

Clorox Co's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Jun 30, 2026 · FY), Clorox Co reported revenue of $6.7B (-5.4% year on year) and net income of $601.0M (-27.1% year on year).

Income statement

Clorox Co income statement, fiscal years

Line item	Jun 30, 2026 · FY	Jun 30, 2025 · FY	Jun 30, 2024 · FY	Jun 30, 2023 · FY
Net sales	$6.7B	$7.1B	$7.1B	$7.4B
Cost of products sold	$3.9B	$3.9B	$4.0B	$4.5B
Gross profit	$2.8B	$3.2B	$3.0B	$2.9B
Selling and administrative expenses	$1.1B	$1.1B	$1.2B	$1.2B
Advertising costs	$749.0M	$770.0M	$832.0M	$734.0M
Research and development costs	$116.0M	$121.0M	$126.0M	$138.0M
Loss on divestiture	$0	$118.0M	$240.0M	—
Pension settlement charge	$0	$0	$171.0M	—
Interest expense	$130.0M	$88.0M	$90.0M	$90.0M
Other (income) expense, net	($8.0M)	($86.0M)	$24.0M	$80.0M
Earnings before income taxes	$791.0M	$1.1B	$398.0M	$238.0M
Income taxes	$190.0M	$254.0M	$106.0M	$77.0M
Net earnings	$601.0M	$824.0M	$292.0M	$161.0M
Less: Net earnings attributable to noncontrolling interests	$14.0M	$14.0M	$12.0M	$12.0M
Net earnings attributable to Clorox	$587.0M	$810.0M	$280.0M	$149.0M
Basic net earnings per share (in dollars per share)	$4.82	$6.56	$2.26	$1.21
Diluted net earnings per share (in dollars per share)	$4.81	$6.52	$2.25	$1.20
Basic (in shares)	121.8M	123.5M	124.2M	123.6M
Diluted (in shares)	122.1M	124.3M	124.8M	124.2M

Clorox Co income statement, quarters

Line item	Mar 31, 2026 · Q3	Dec 31, 2025 · Q2	Sep 30, 2025 · Q1	Mar 31, 2025 · Q3
Net sales	$1.7B	$1.7B	$1.4B	$1.7B
Cost of products sold	$948.0M	$951.0M	$833.0M	$924.0M
Gross profit	$722.0M	$722.0M	$596.0M	$744.0M
Selling and administrative expenses	$229.0M	$262.0M	$277.0M	$267.0M
Advertising costs	$177.0M	$190.0M	$166.0M	$207.0M
Research and development costs	$27.0M	$29.0M	$28.0M	$27.0M
Loss on divestiture	$0	$0	$0	$0
Interest expense	$27.0M	$25.0M	$23.0M	$23.0M
Other (income) expense, net	$6.0M	$1.0M	($5.0M)	($34.0M)
Earnings before income taxes	$256.0M	$215.0M	$107.0M	$254.0M
Income tax expense	$65.0M	$54.0M	$25.0M	$63.0M
Net earnings	$191.0M	$161.0M	$82.0M	$191.0M
Less: Net earnings attributable to noncontrolling interests	$4.0M	$4.0M	$2.0M	$5.0M
Net earnings attributable to Clorox	$187.0M	$157.0M	$80.0M	$186.0M
Basic net earnings per share (in dollars per share)	$1.54	$1.29	$0.65	$1.51
Diluted net earnings per share (in dollars per share)	$1.54	$1.29	$0.65	$1.50
Basic (in shares)	121.4M	121.6M	122.6M	123.4M
Diluted (in shares)	121.8M	121.9M	123.0M	124.1M

Balance sheet

Clorox Co balance sheet, fiscal years

Line item	Jun 30, 2026 · FY	Jun 30, 2025 · FY	Jun 30, 2024 · FY	Jun 30, 2023 · FY
Cash and cash equivalents	$143.0M	$167.0M	$202.0M	$367.0M
Receivables, net	$791.0M	$821.0M	$695.0M	$688.0M
Inventories, net	$777.0M	$523.0M	$637.0M	$696.0M
Prepaid expenses and other current assets	$113.0M	$97.0M	$88.0M	$77.0M
Total current assets	$1.8B	$1.6B	$1.6B	$1.8B
Property, plant and equipment, net	$1.5B	$1.3B	$1.3B	$1.3B
Operating lease right-of-use assets	$401.0M	$333.0M	$360.0M	$346.0M
Goodwill	$1.9B	$1.2B	$1.2B	$1.3B
Trademarks, net	$989.0M	$502.0M	$538.0M	$543.0M
Other intangible assets, net	$606.0M	$64.0M	$143.0M	$169.0M
Other assets	$517.0M	$558.0M	$545.0M	$462.0M
Total assets	$7.8B	$5.6B	$5.8B	$5.9B
Notes and loans payable	$1.1B	$4.0M	$4.0M	$50.0M
Current maturities of long-term debt	$1.0M	—	—	—
Current operating lease liabilities	$86.0M	$87.0M	$84.0M	$87.0M
Accounts payable and accrued liabilities	$1.6B	$1.8B	$1.5B	$1.7B
Total current liabilities	$2.8B	$1.9B	$1.6B	$1.9B
Long-term debt	$4.0B	$2.5B	$2.5B	$2.5B
Long-term operating lease liabilities	$366.0M	$305.0M	$334.0M	$310.0M
Other liabilities	$405.0M	$351.0M	$848.0M	$825.0M
Deferred income taxes	$17.0M	$20.0M	$22.0M	$28.0M
Total liabilities	$7.5B	$5.1B	$5.3B	$5.6B
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2026 and 2025; and 120,926,454 and 122,694,263 shares outstanding as of June 30, 2026 and 2025, respectively	131.0M	131.0M	131.0M	131.0M
Additional paid-in capital	$1.3B	$1.3B	$1.3B	$1.2B
Retained earnings	$386.0M	$432.0M	$250.0M	$583.0M
Treasury stock, at cost: 9,815,007 and 8,047,198 shares as of June 30, 2026 and 2025, respectively	-1.6B	-1.4B	-1.2B	-1.2B
Accumulated other comprehensive net (loss) income	($157.0M)	($157.0M)	($155.0M)	($493.0M)
Total Clorox stockholders’ equity	$90.0M	$321.0M	$328.0M	$220.0M
Noncontrolling interests	$162.0M	$161.0M	$164.0M	$168.0M
Total stockholders’ equity	$252.0M	$482.0M	$492.0M	$388.0M
Total liabilities and stockholders’ equity	$7.8B	$5.6B	$5.8B	$5.9B

Clorox Co balance sheet, quarters

Line item	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Mar 31, 2025
Cash and cash equivalents	$1.2B	$227.0M	$166.0M	$226.0M
Receivables, net	$671.0M	$671.0M	$703.0M	$597.0M
Inventories, net	$588.0M	$608.0M	$577.0M	$635.0M
Prepaid expenses and other current assets	$205.0M	$222.0M	$249.0M	$132.0M
Total current assets	$2.7B	$1.7B	$1.7B	$1.6B
Property, plant and equipment, net of accumulated depreciation and amortization of $3,044 and $2,911, respectively	$1.2B	$1.2B	$1.3B	$1.2B
Operating lease right-of-use assets	$355.0M	$368.0M	$318.0M	$349.0M
Goodwill	$1.2B	$1.2B	$1.2B	$1.2B
Trademarks, net	$502.0M	$502.0M	$502.0M	$501.0M
Other intangible assets, net	$49.0M	$54.0M	$59.0M	$68.0M
Other assets	$415.0M	$483.0M	$476.0M	$537.0M
Total assets	$6.4B	$5.6B	$5.5B	$5.5B
Notes and loans payable	$1.6B	$307.0M	$218.0M	$54.0M
Current operating lease liabilities	$85.0M	$83.0M	$89.0M	$85.0M
Accounts payable and accrued liabilities	$1.5B	$2.0B	$1.9B	$2.0B
Total current liabilities	$3.2B	$2.3B	$2.2B	$2.2B
Long-term debt	$2.5B	$2.5B	$2.5B	$2.5B
Long-term operating lease liabilities	$323.0M	$341.0M	$286.0M	$322.0M
Other liabilities	$356.0M	$385.0M	$365.0M	$341.0M
Deferred income taxes	$23.0M	$19.0M	$20.0M	$21.0M
Total liabilities	$6.3B	$5.6B	$5.4B	$5.3B
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2026 and June 30, 2025; and 120,920,243 and 122,694,263 shares outstanding as of March 31, 2026 and June 30, 2025, respectively	131.0M	131.0M	131.0M	131.0M
Additional paid-in capital	$1.3B	$1.3B	$1.3B	$1.3B
Retained earnings	$223.0M	$190.0M	$200.0M	$99.0M
Treasury stock, at cost: 9,821,218 and 8,047,198 shares as of March 31, 2026 and June 30, 2025, respectively	-1.6B	-1.6B	-1.5B	—
Accumulated other comprehensive net (loss) income	($152.0M)	($159.0M)	($165.0M)	($176.0M)
Total Clorox stockholders’ (deficit) equity	($67.0M)	($125.0M)	($22.0M)	$27.0M
Noncontrolling interests	$159.0M	$160.0M	$160.0M	$163.0M
Total stockholders’ equity	$92.0M	$35.0M	$138.0M	$190.0M
Total liabilities and stockholders’ equity	$6.4B	$5.6B	$5.5B	$5.5B

Cash flow statement

Clorox Co cash flow statement, fiscal years

Line item	Jun 30, 2026 · FY	Jun 30, 2025 · FY	Jun 30, 2024 · FY	Jun 30, 2023 · FY
Net earnings	$601.0M	$824.0M	$292.0M	$161.0M
Depreciation and amortization	$247.0M	$219.0M	$235.0M	$236.0M
Stock-based compensation	$48.0M	$81.0M	$74.0M	$73.0M
Deferred income taxes	$81.0M	($18.0M)	($100.0M)	($149.0M)
Venture agreement payment	$476.0M	—	—	—
Loss on divestiture	$0	$112.0M	$238.0M	—
Pension settlement charge	$0	$0	$171.0M	—
Other	($7.0M)	($26.0M)	$26.0M	$38.0M
Receivables, net	$151.0M	($145.0M)	($34.0M)	($13.0M)
Inventories, net	($71.0M)	$63.0M	$55.0M	$58.0M
Prepaid expenses and other current assets	$2.0M	($9.0M)	$25.0M	($1.0M)
Accounts payable and accrued liabilities	$38.0M	($124.0M)	($140.0M)	$157.0M
Operating lease right-of-use assets and liabilities, net	($4.0M)	$2.0M	$0	$1.0M
Income taxes payable/prepaid	$2.0M	$2.0M	($147.0M)	$152.0M
Net cash provided by operations	$612.0M	$981.0M	$695.0M	$1.2B
Capital expenditures	($207.0M)	($220.0M)	($212.0M)	($228.0M)
Business acquired, net of cash acquired	($2.1B)	—	—	$0
Proceeds from divestiture, net of cash divested	$0	$128.0M	$17.0M	—
Other	$10.0M	($2.0M)	$20.0M	$5.0M
Net cash used for investing activities	($2.3B)	($94.0M)	($175.0M)	($223.0M)
Notes and loans payable, net	$1.1B	$0	($45.0M)	($188.0M)
Debt borrowings, net of issuance costs paid	$2.7B	—	—	—
Debt repayments	($1.3B)	—	—	—
Treasury stock purchased	($256.0M)	($332.0M)	$0	$0
Cash dividends paid to Clorox stockholders	($602.0M)	($602.0M)	($595.0M)	($583.0M)
Cash dividends paid to noncontrolling interests	($16.0M)	($16.0M)	($16.0M)	($15.0M)
Issuance of common stock for employee stock plans and other	($23.0M)	$26.0M	$1.0M	$33.0M
Net cash provided by (used for) financing activities	$1.7B	($924.0M)	($655.0M)	($753.0M)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	($2.0M)	$0	($26.0M)	$0
Net increase (decrease) in cash, cash equivalents and restricted cash	($23.0M)	($37.0M)	($161.0M)	$182.0M
Beginning of year	$170.0M	$207.0M	$368.0M	$186.0M
End of year	$147.0M	$170.0M	$207.0M	$368.0M
Interest paid	$122.0M	$97.0M	$102.0M	$99.0M
Income taxes paid, net of refunds	$104.0M	$264.0M	$347.0M	$73.0M
Cash dividends declared and accrued, but not paid	$16.0M	$16.0M	$16.0M	$16.0M

Clorox Co cash flow statement, quarters

Line item	Mar 31, 2026 · YTD	Dec 31, 2025 · YTD	Sep 30, 2025 · Q1	Mar 31, 2025 · YTD
Net earnings	$434.0M	$243.0M	$82.0M	$488.0M
Depreciation and amortization	$169.0M	$111.0M	$56.0M	$162.0M
Stock-based compensation	$49.0M	$34.0M	$10.0M	$64.0M
Deferred income taxes	$135.0M	$92.0M	$84.0M	($16.0M)
Venture Agreement termination payment	($476.0M)	—	—	—
Loss on divestiture	$0	$0	$0	$112.0M
Other	($18.0M)	($16.0M)	($12.0M)	($9.0M)
Receivables, net	$158.0M	$156.0M	$118.0M	$71.0M
Inventories, net	($64.0M)	($83.0M)	($55.0M)	($54.0M)
Prepaid expenses and other current assets	($14.0M)	($30.0M)	($41.0M)	($28.0M)
Accounts payable and accrued liabilities	($12.0M)	($6.0M)	($40.0M)	($87.0M)
Operating lease right-of-use assets and liabilities, net	($5.0M)	($4.0M)	($2.0M)	$1.0M
Income taxes payable / prepaid	($74.0M)	($93.0M)	($107.0M)	($17.0M)
Net cash provided by operations	$282.0M	$404.0M	$93.0M	$687.0M
Capital expenditures	($121.0M)	($78.0M)	($36.0M)	($145.0M)
Proceeds from divestiture, net of cash divested	$0	$0	$0	$128.0M
Other	$1.0M	$1.0M	$2.0M	($1.0M)
Net cash used for investing activities	($120.0M)	($77.0M)	($34.0M)	($18.0M)
Notes and loans payable, net	$1.6B	$303.0M	$214.0M	$50.0M
Treasury stock purchased	($256.0M)	($256.0M)	($129.0M)	($257.0M)
Cash dividends paid to Clorox stockholders	($452.0M)	($302.0M)	($151.0M)	($452.0M)
Cash dividends paid to noncontrolling interests	$0	—	—	($16.0M)
Issuance of common stock for employee stock plans and other	($16.0M)	($14.0M)	$7.0M	$30.0M
Net cash provided by (used for) financing activities	$857.0M	($269.0M)	($59.0M)	($645.0M)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	($2.0M)	$1.0M	($1.0M)	($2.0M)
Net increase (decrease) in cash, cash equivalents and restricted cash	$1.0B	$59.0M	($1.0M)	$22.0M
Beginning of period	$170.0M	$170.0M	$170.0M	$207.0M
End of period	$1.2B	$229.0M	$169.0M	$229.0M

Clorox Co score and earnings-call analysis · All covered companies

Figures as reported in SEC filings. General information, not investment advice.